Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT00408772
Title Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Treating Patients With Colorectal Cancer That Has Spread to the Liver and Cannot Be Removed By Surgery
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, Davis

colorectal adenocarcinoma


Bevacizumab + Capecitabine + Oxaliplatin

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of California Davis Cancer Center Sacramento California 95817 United States Details
*Shaded cells indicate that there was no data available from for the field